229 related articles for article (PubMed ID: 26749795)
21. Prevention of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates.
DE Iuliis F; Taglieri L; Amoroso L; Vendittozzi S; Blasi L; Salerno G; Lanza R; Scarpa S
Anticancer Res; 2014 May; 34(5):2477-80. PubMed ID: 24778063
[TBL] [Abstract][Full Text] [Related]
22. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
Khan AA; Sándor GK; Dore E; Morrison AD; Alsahli M; Amin F; Peters E; Hanley DA; Chaudry SR; Dempster DW; Glorieux FH; Neville AJ; Talwar RM; Clokie CM; Al Mardini M; Paul T; Khosla S; Josse RG; Sutherland S; Lam DK; Carmichael RP; Blanas N; Kendler D; Petak S; St-Marie LG; Brown J; Evans AW; Rios L; Compston JE;
J Rheumatol; 2008 Jul; 35(7):1391-7. PubMed ID: 18528958
[TBL] [Abstract][Full Text] [Related]
23. Osteonecrosis of the jaw after implant surgery in patients treated with bisphosphonates--a presentation of six consecutive cases.
Tam Y; Kar K; Nowzari H; Cha HS; Ahn KM
Clin Implant Dent Relat Res; 2014 Oct; 16(5):751-61. PubMed ID: 23445465
[TBL] [Abstract][Full Text] [Related]
24. Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series.
López-Cedrún JL; Sanromán JF; García A; Peñarrocha M; Feijoo JF; Limeres J; Diz P
Br J Oral Maxillofac Surg; 2013 Dec; 51(8):874-9. PubMed ID: 23866309
[TBL] [Abstract][Full Text] [Related]
25. Effect of local vs. systemic bisphosphonate delivery on dental implant fixation in a model of osteonecrosis of the jaw.
Abtahi J; Agholme F; Sandberg O; Aspenberg P
J Dent Res; 2013 Mar; 92(3):279-83. PubMed ID: 23264610
[TBL] [Abstract][Full Text] [Related]
26. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
27. Previously successful dental implants can fail when patients commence anti-resorptive therapy-a case series.
Pogrel MA; Ruggiero SL
Int J Oral Maxillofac Surg; 2018 Feb; 47(2):220-222. PubMed ID: 28803735
[TBL] [Abstract][Full Text] [Related]
28. [Focus: Drug-related osteonecrosis of the jaw].
Schmouchkovitch A; Remaud M; Simon H; Herry H; Le Toux G; Boisramé S
Presse Med; 2018 Jan; 47(1):19-33. PubMed ID: 29275972
[TBL] [Abstract][Full Text] [Related]
29. The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series.
Goss A; Bartold M; Sambrook P; Hawker P
J Oral Maxillofac Surg; 2010 Feb; 68(2):337-43. PubMed ID: 20116705
[TBL] [Abstract][Full Text] [Related]
30. [Bisphosphonates and osteonecrosis of the jaws].
Urade M
Clin Calcium; 2007 Feb; 17(2):241-8. PubMed ID: 17272882
[TBL] [Abstract][Full Text] [Related]
31. Dental implications of bisphophonate-related osteonecrosis.
Saldanha S; Shenoy VK; Eachampati P; Uppal N
Gerodontology; 2012 Sep; 29(3):177-87. PubMed ID: 22486711
[TBL] [Abstract][Full Text] [Related]
32. Animal model for medication-related osteonecrosis of the jaw with precedent metabolic bone disease.
Kim JW; Tatad JCI; Landayan MEA; Kim SJ; Kim MR
Bone; 2015 Dec; 81():442-448. PubMed ID: 26297440
[TBL] [Abstract][Full Text] [Related]
33. Bisphosphonate-associated Osteonecrosis of the jaws: a guide for the general dental practitioner.
Barker K; Rogers S
Dent Update; 2006 Jun; 33(5):270-2, 275. PubMed ID: 16841609
[TBL] [Abstract][Full Text] [Related]
34. [Bisphosphonate-related osteonecrosis of the jaw].
Atanes-Bonome P; Atanes-Bonome A; Ríos-Lage P; Atanes-Sandoval AD
Semergen; 2014 Apr; 40(3):143-8. PubMed ID: 24001573
[TBL] [Abstract][Full Text] [Related]
35. Dental extractions in patient treated with intravenous bisphosphonates and risk of osteonecrosis of jaws: presentation of a preventive protocol and case series.
Ferlito S; Liardo C; Puzzo S
Minerva Stomatol; 2010; 59(11-12):593-601. PubMed ID: 21217623
[TBL] [Abstract][Full Text] [Related]
36. Antiresorptives and osteonecrosis of the jaw.
Yamashita J; McCauley LK
J Evid Based Dent Pract; 2012 Sep; 12(3 Suppl):233-47. PubMed ID: 23040351
[TBL] [Abstract][Full Text] [Related]
37. The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan.
Yuh DY; Chang TH; Huang RY; Chien WC; Lin FG; Fu E
J Dent; 2014 Oct; 42(10):1343-52. PubMed ID: 24907558
[TBL] [Abstract][Full Text] [Related]
38. Bisphosphonate and Implant Dentistry - Is it Safe?
Thirunavukarasu A; Pinto HG; Seymour KG
Prim Dent J; 2015 Aug; 4(3):30-3. PubMed ID: 26556516
[TBL] [Abstract][Full Text] [Related]
39. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices.
Fugazzotto PA; Lightfoot WS; Jaffin R; Kumar A
J Periodontol; 2007 Sep; 78(9):1664-9. PubMed ID: 17760533
[TBL] [Abstract][Full Text] [Related]
40. Implant Placement Adjacent to Successfully Treated Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ).
Rugani P; Kirnbauer B; Acham S; Truschnegg A; Jakse N
J Oral Implantol; 2015 Jul; 41 Spec No():377-81. PubMed ID: 24593250
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
